WIDDER KENNETH J - 21 May 2025 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Kenneth J. Widder
Issuer symbol
EVOK
Transactions as of
21 May 2025
Transactions value $
$0
Form type
4
Filing time
22 May 2025, 17:00:20 UTC
Previous filing
20 May 2025
Next filing
27 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WIDDER KENNETH J Director C/O EVOKE PHARMA, INC., 420 STEVENS AVENUE, SUITE 230, SOLANA BEACH /s/ Matthew J. D'Onofrio, Attorney-in-fact for Kenneth J. Widder 22 May 2025 0001065168

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +1.19K +16.91% $0.00 8.21K 21 May 2025 Common Stock 1.19K $3.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.